[#item_full_content]COLLEGEVILLE, Pa.–(BUSINESS WIRE)– #TAVI–Thubrikar Aortic Valve, Inc. today announced successful results in the first two patients implanted with the Optimum Transcatheter Aortic Valve (Optimum TAV™) using the new Precision 2™ Delivery Catheter. Interventional Cardiologist and TAVI-1 Study Principal Investigator, Jaroslaw Trebacz, MD, performed the procedures at the John Paul II Hospital in Krakow, Poland. “The first two implants with the 2nd-generation delivery catheter could not be easier or more